🇺🇸 FDA
Patent

US 11008564

Processing engineered FMDV P1 polypeptide using an alternative TEV protease

granted A61KA61K2039/523A61K2039/5254

Quick answer

US patent 11008564 (Processing engineered FMDV P1 polypeptide using an alternative TEV protease) held by The Government of the United States of America, as represented by the Secretary of Homeland Security expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary of Homeland Security
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/523, A61K2039/5254, A61K2039/5258, A61K39/12